High prevalence of left ventricle diastolic dysfunction in severe COPD associated with a low exercise capacity: A cross-sectional study

Background: a subclinical left ventricle diastolic dysfunction (LVDD) has been described in patients with chronic obstructive pulmonary disease (COPD). Objectives: to evaluate the prevalence of LVDD in stable severe COPD patients, to analyze its relationship with exercise capacity and to look for it...

Descripción completa

Detalles Bibliográficos
Autores: López Sánchez, Marta, Muñoz Esquerre, Mariana, Huertas, Daniel, González-Costello, José, Ribas, Jesús, Manresa, Federico, Dorca i Sargatal, Jordi, Santos Pérez, Salud
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2013
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/104025
Acceso en línea:https://hdl.handle.net/2445/104025
Access Level:acceso abierto
Palabra clave:Malalties pulmonars obstructives cròniques
Malalties del pulmó
Ventricles cardíacs
Malalties cardiovasculars
Exercici
Chronic obstructive pulmonary diseases
Pulmonary diseases
Ventricle of heart
Cardiovascular diseases
Exercise
Descripción
Sumario:Background: a subclinical left ventricle diastolic dysfunction (LVDD) has been described in patients with chronic obstructive pulmonary disease (COPD). Objectives: to evaluate the prevalence of LVDD in stable severe COPD patients, to analyze its relationship with exercise capacity and to look for its possible causes (lung hyperinflation, ventricular interdependence or inflammatory mechanisms). Methods: we evaluated 106 consecutive outpatients with severe COPD (FEV1 between 30-50%). Thirty-three (31%) were excluded because of previous heart disease. A pulmonary function test, a 6-minute walking test (6MWT), a Doppler echocardiography test, including diastolic dysfunction parameters, and an analysis of arterial blood gases, NT-proBNP and serum inflammatory markers (CRP, leucocytes), were performed in all patients. Results: the prevalence of LVDD in severe stable COPD patients was 90% (80% type I, n=57, and 10% type II, n=7). A significant association between a lower E/A ratio (higher LVDD type I) and a lower exercise tolerance (6-minute walked distance (6MWD)) was found (r=0.29, p<0.05). The fully adjusted multivariable linear regression model demonstrated that a lower E/A ratio, a DLCO in the quartile 4th and a higher tobacco consumption were associated with a lower 6MWD (76, 57 and 0.7 metres, respectively, p<0.05). A significant correlation between E/A ratio and PaO2 was observed (r=0.26, p<0.05), but not with static lung hyperinflation, inflammation or right ventricle overload parameters. Conclusion: in stable severe COPD patients, the prevalence of LVDD is high and this condition might contribute in their lower exercise tolerance. Hypoxemia could have a concomitant role in their pathogenesis.